Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03393351
Other study ID # SCHO 1551/1-2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 5, 2018
Est. completion date December 31, 2020

Study information

Verified date June 2021
Source Universitätsklinikum Hamburg-Eppendorf
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to evaluate a theoretically and empirically grounded implementation program designed to foster shared decision-making in routine cancer care. The intervention program consists of several components (e.g. training for health care professionals, patient empowerment strategies) that will be rolled out in three clinics at a comprehensive cancer center in Germany.


Recruitment information / eligibility

Status Completed
Enrollment 2131
Est. completion date December 31, 2020
Est. primary completion date September 12, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria for participating patients: - diagnosed with neoplasms (ICD 10: C00-D49, excluding D10-D36) - admitted for inpatient or outpatient treatment at the participating clinics - age > 18 years - German-speaking Exclusion Criteria for participating patients: - severe cognitive impairment Inclusion Criteria for participating health care professionals: - physician or nurse working at the participating clinics Exclusion Criteria for participating health care professionals: - none

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Shared decision-making program
The intervention is shared decision-making. The implementation strategy to foster shared decision-making in routine cancer care is a multicomponent implementation program. The implementation program consists of the following components: shared decision-making trainings for health care professionals, individual coaching for physicians, patient activation strategy, provision of patient information material and decision aids, revision of the clinics quality management documents, and critical reflection of current organization of multidisciplinary team meetings. Implementation: after baseline assessment (t0) for clinic 1, after assessment at t1 for clinic 2, after assessment at t2 for clinic 3.
Usual Care
No specific study related intervention. Treatment decisions are made according to current routine practice at the comprehensive cancer center in Germany.

Locations

Country Name City State
Germany University Medical Center Hamburg-Eppendorf, Center for Oncology, II. Medical Clinic and Polyclinic Hamburg
Germany University Medical Center Hamburg-Eppendorf, Center for Surgical Sciences, Department of Gynecology Hamburg
Germany University Medical Center Hamburg-Eppendorf, Head and Neurocenter, Department of Oral and Maxillofacial Surgery Hamburg

Sponsors (1)

Lead Sponsor Collaborator
Universitätsklinikum Hamburg-Eppendorf

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Scholl I, Hahlweg P, Lindig A, Bokemeyer C, Coym A, Hanken H, Müller V, Smeets R, Witzel I, Kriston L, Härter M. Evaluation of a program for routine implementation of shared decision-making in cancer care: study protocol of a stepped wedge cluster randomized trial. Implement Sci. 2018 Mar 27;13(1):51. doi: 10.1186/s13012-018-0740-y. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in uptake of shared decision-making from the patients' perspective Action to employ shared decision-making as measured by the German version of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) All clinics: baseline, 8 months, 16 months, 24 months
Secondary Change in uptake of shared decision-making from external observers' perspective Action to employ shared decision-making as measured by the German version of the Observer OPTION 5 scale using audio-recorded medical encounters. The Observer OPTION 5 scale measures the extent to which clinicians involve patients in decision-making. Each of the 5 items is assessed on a scale ranging from 0 to 4 with higher values indicating more involvement of patients in decision-making. A sum score is calculated (ranging from 0 to 20) and rescaled to be between 0 to 100, for ease of interpretation. All clinics: baseline, 8 months, 16 months, 24 months
Secondary Acceptability of shared decision-making from the health care providers' perspective Perception that shared decision-making is agreeable, palatable, or satisfactory as measured by an adapted version of the acceptability survey developed by McColl et al. All clinics: baseline, 8 months, 16 months, 24 months
Secondary Readiness for implementing change from the health care professionals' perspective As measured by an adapted version of the Organizational Readiness for Implementing Change (ORIC) measure All clinics: baseline, 8 months, 16 months, 24 months
Secondary Appropriateness of shared decision-making from the health care professionals' perspective Perceived fit, relevance, or compatibility of shared decision-making for the given practice setting as measured by an adapted version of the IcanSDM measure All clinics: baseline, 8 months, 16 months, 24 months
Secondary Change in penetration of shared decision-making at the clinic level Integration of shared decision-making within a setting and its subsystems as measured by routine data from patient experience surveys of the clinics baseline, 3 years
Secondary Change in penetration of shared decision-making in multidisciplinary team meetings Integration of shared decision-making within a setting and its subsystems as measured by an adapted version of the Metric for the Observation of Decision Making in Multidisciplinary Team Meetings (MDT-MODe) All clinics: baseline, 8 months, 16 months, 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases